Amarantus Bioscience Holdings Inc (AMBS)
0.0001
0.00 (0.00%)
USD |
OTCM |
May 08, 12:12
Amarantus Bioscience Holdings Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2011 | -0.277 |
| September 30, 2011 | -0.2179 |
| June 30, 2011 | -0.1929 |
| April 30, 2011 | -0.1066 |
| January 31, 2011 | -0.1215 |
| October 31, 2010 | -0.167 |
| July 31, 2010 | -0.2114 |
| April 30, 2010 | -0.2815 |
| January 31, 2010 | -0.6752 |
| Date | Value |
|---|---|
| October 31, 2009 | -0.7058 |
| July 31, 2009 | -1.198 |
| April 30, 2009 | -0.7538 |
| January 31, 2009 | 11.11 |
| October 31, 2008 | 0.00 |
| July 31, 2008 | 0.00 |
| April 30, 2008 | 0.00 |
| January 31, 2008 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 10.18M |
| Total Liabilities (Quarterly) | 31.57M |
| Shareholders Equity (Quarterly) | -21.39M |